Market Indices

Close · Sep 23, 2026

Latest News

Novo Nordisk and Eli Lilly: The Competitive Race in the GLP-1 Market Unveiled

As the race in the GLP-1 market intensifies, Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) stand at distinct crossroads in their growth trajectories. Eli Lilly currently leads the market, enjoying a larger share and the potential for extended exclusivity for its products. This scenario raises significant questions about Novo Nordisk’s competitive strategies as...


Price Targets

All News

Annual/Quarterly Reports Summary

All News